{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T19:28:23Z","timestamp":1649100503495},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Netw Model Anal Health Inform Bioinforma"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s13721-018-0173-1","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T04:14:10Z","timestamp":1534220050000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Decoding methylation patterns in ovarian cancer using publicly available Next-Gen sequencing data"],"prefix":"10.1007","volume":"7","author":[{"given":"Prashant","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utkarsh","family":"Raj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imlimaong","family":"Aier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pritish Kumar","family":"Varadwaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,14]]},"reference":[{"key":"173_CR1","doi-asserted-by":"publisher","first-page":"e1003326","DOI":"10.1371\/journal.pcbi.1003326","volume":"9","author":"T Bailey","year":"2013","unstructured":"Bailey T, Krajewski P, Ladunga I et al (2013) Practical guidelines for the comprehensive analysis of ChIP-seq data. PLoS Comput Biol 9:e1003326","journal-title":"PLoS Comput Biol"},{"key":"173_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrc1799","volume":"6","author":"SB Baylin","year":"2006","unstructured":"Baylin SB, Ohm JE (2006) Epigenetic gene silencing in cancer\u2014a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6:107\u2013116. https:\/\/doi.org\/10.1038\/nrc1799","journal-title":"Nat Rev Cancer"},{"key":"173_CR3","unstructured":"Bioinformatics B (2011) FastQC: a quality control tool for high throughput sequence data. Camb UK Babraham Inst"},{"key":"173_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0092-8674(00)81532-9","volume":"99","author":"AP Bird","year":"1999","unstructured":"Bird AP, Wolffe AP (1999) Methylation-induced repression\u2014belts, braces, and chromatin. Cell 99:451\u2013454. https:\/\/doi.org\/10.1016\/S0092-8674(00)81532-9","journal-title":"Cell"},{"key":"173_CR5","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1038\/sj.onc.1202509","volume":"18","author":"A Catteau","year":"1999","unstructured":"Catteau A, Harris WH, Xu C-F, Solomon E (1999) Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 18:1957\u20131965. https:\/\/doi.org\/10.1038\/sj.onc.1202509","journal-title":"Oncogene"},{"key":"173_CR6","doi-asserted-by":"publisher","first-page":"554","DOI":"10.5483\/BMBRep.2010.43.8.554","volume":"43","author":"C Chen","year":"2010","unstructured":"Chen C, Sun M-Z, Liu S et al (2010) Smad4 mediates malignant behaviors of human ovarian carcinoma cell through the effect on expressions of E-cadherin, plasminogen activator inhibitor-1 and VEGF. Bmb Rep 43:554\u2013560","journal-title":"Bmb Rep"},{"key":"173_CR7","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.18632\/oncotarget.6510","volume":"7","author":"EJ Choi","year":"2016","unstructured":"Choi EJ, Seo EJ, Kim DK et al (2016) FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells. Oncotarget 7:3506","journal-title":"Oncotarget"},{"key":"173_CR8","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/ni1454","volume":"8","author":"C Cobaleda","year":"2007","unstructured":"Cobaleda C, Schebesta A, Delogu A, Busslinger M (2007) Pax5: the guardian of B cell identity and function. Nat Immunol 8:463","journal-title":"Nat Immunol"},{"key":"173_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/jmg.38.5.285","volume":"38","author":"JF Costello","year":"2001","unstructured":"Costello JF, Plass C (2001) Methylation matters. J Med Genet 38:285\u2013303","journal-title":"J Med Genet"},{"key":"173_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ygyno.2009.05.012","volume":"114","author":"KM Darcy","year":"2009","unstructured":"Darcy KM, Brady WE, Blancato JK et al (2009) Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: a gynecologic oncology Group study. Gynecol Oncol 114:472\u2013479. https:\/\/doi.org\/10.1016\/j.ygyno.2009.05.012","journal-title":"Gynecol Oncol"},{"key":"173_CR11","doi-asserted-by":"crossref","unstructured":"Elias KM, Emori MM, Westerling T et al (2016) Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors. JCI Insight 1","DOI":"10.1172\/jci.insight.87988"},{"key":"173_CR12","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra072067","volume":"358","author":"M Esteller","year":"2008","unstructured":"Esteller M (2008) Epigenetics in cancer. N Engl J Med 358:1148\u20131159. https:\/\/doi.org\/10.1056\/NEJMra072067","journal-title":"N Engl J Med"},{"key":"173_CR13","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/jnci\/92.7.564","volume":"92","author":"M Esteller","year":"2000","unstructured":"Esteller M, Silva JM, Dominguez G et al (2000) Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors. JNCI J Natl Cancer Inst 92:564\u2013569. https:\/\/doi.org\/10.1093\/jnci\/92.7.564","journal-title":"JNCI J Natl Cancer Inst"},{"key":"173_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1476-4598-11-84","volume":"11","author":"N Goncharenko-Khaider","year":"2012","unstructured":"Goncharenko-Khaider N, Matte I, Lane D et al (2012) Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1\/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis. Mol Cancer 11:84","journal-title":"Mol Cancer"},{"key":"173_CR15","first-page":"177","volume":"22","author":"S Hein","year":"2009","unstructured":"Hein S, Mahner S, Kanowski C et al (2009) Expression of Jun and Fos proteins in ovarian tumors of different malignant potential and in ovarian cancer cell lines. Oncol Rep 22:177\u2013183","journal-title":"Oncol Rep"},{"key":"173_CR16","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1056\/NEJMra023075","volume":"349","author":"JG Herman","year":"2003","unstructured":"Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042\u20132054. https:\/\/doi.org\/10.1056\/NEJMra023075","journal-title":"N Engl J Med"},{"key":"173_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1006\/bbrc.2001.5578","volume":"287","author":"I Imoto","year":"2001","unstructured":"Imoto I, Sonoda I, Yuki Y, Inazawa J (2001) Identification and characterization of human PKNOX2, a novel homeobox-containing gene. Biochem Biophys Res Commun 287:270\u2013276","journal-title":"Biochem Biophys Res Commun"},{"key":"173_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/oxfordjournals.humrep.a136832","volume":"4","author":"I Jacobs","year":"1989","unstructured":"Jacobs I, Bast RC (1989) The CA 125 tumour-associated antigen: a review of the literature. Hum Reprod 4:1\u201312. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a136832","journal-title":"Hum Reprod"},{"key":"173_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","volume":"55","author":"A Jemal","year":"2005","unstructured":"Jemal A, Murray T, Ward E et al (2005) Cancer Statistics, 2005. CA Cancer J Clin 55:10\u201330. https:\/\/doi.org\/10.3322\/canjclin.55.1.10","journal-title":"CA Cancer J Clin"},{"key":"173_CR20","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1141319","volume":"316","author":"DS Johnson","year":"2007","unstructured":"Johnson DS, Mortazavi A, Myers RM, Wold B (2007) Genome-wide mapping of in vivo protein-DNA interactions. Science 316:1497\u20131502","journal-title":"Science"},{"key":"173_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/mmr.2014.2221","volume":"10","author":"O Koukoura","year":"2014","unstructured":"Koukoura O, Spandidos DA, Daponte A, Sifakis S (2014) DNA methylation profiles in ovarian cancer: Implication in diagnosis and therapy (Review). Mol Med Rep 10:3\u20139","journal-title":"Mol Med Rep"},{"key":"173_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s40010-017-0380-7","author":"H Kumar","year":"2017","unstructured":"Kumar H, Naik PA, Pardasani KR (2017) Finite element model to study calcium distribution in T lymphocyte involving buffers and ryanodine receptors. Proc Natl Acad Sci India Sect Phys Sci. https:\/\/doi.org\/10.1007\/s40010-017-0380-7","journal-title":"Proc Natl Acad Sci India Sect Phys Sci"},{"key":"173_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL (2012) Fast gapped-read alignment with Bowtie 2. Nat Methods 9:357","journal-title":"Nat Methods"},{"key":"173_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nsmb.3180","volume":"23","author":"M Lerdrup","year":"2016","unstructured":"Lerdrup M, Johansen JV, Agrawal-Singh S, Hansen K (2016) An interactive environment for agile analysis and visualization of ChIP-sequencing data. Nat Struct Mol Biol 23:349","journal-title":"Nat Struct Mol Biol"},{"key":"173_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2353\/jmoldx.2009.080072","volume":"11","author":"A Melnikov","year":"2009","unstructured":"Melnikov A, Scholtens D, Godwin A, Levenson V (2009) Differential methylation profile of ovarian cancer in tissues and plasma. J Mol Diagn 11:60\u201365. https:\/\/doi.org\/10.2353\/jmoldx.2009.080072","journal-title":"J Mol Diagn"},{"key":"173_CR26","unstructured":"Naik PA, Pardasani KR (2015) One dimensional finite element model to study calcium distribution in oocytes in presence of VGCC, RyR and Buffers. http:\/\/www.ingentaconnect.com\/content\/asp\/jmihi\/2015\/00000005\/00000003\/art00005 . Accessed 20 May 2018"},{"key":"173_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ajme.2015.02.002","volume":"52","author":"PA Naik","year":"2016","unstructured":"Naik PA, Pardasani KR (2016) Finite element model to study calcium distribution in oocytes involving voltage gated Ca2 + channel, ryanodine receptor and buffers. Alex J Med 52:43\u201349. https:\/\/doi.org\/10.1016\/j.ajme.2015.02.002","journal-title":"Alex J Med"},{"key":"173_CR28","unstructured":"Naik PA, Pardasani KR (2018) Three-dimensional finite element model to study effect of RyR calcium channel, ER Leak and SERCA Pump on Calcium Distribution in Oocyte Cell. Int J Comput Methods 1850091"},{"key":"173_CR29","doi-asserted-by":"publisher","first-page":"15213","DOI":"10.1074\/jbc.274.21.15213","volume":"274","author":"L Ortiz","year":"1999","unstructured":"Ortiz L, Aza-Blanc P, Zannini M et al (1999) The interaction between the forkhead thyroid transcription factor TTF-2 and the constitutive factor CTF\/NF-1 is required for efficient hormonal regulation of the thyroperoxidase gene transcription. J Biol Chem 274:15213\u201315221","journal-title":"J Biol Chem"},{"key":"173_CR30","doi-asserted-by":"crossref","unstructured":"Raj U, Varadwaj PK (2017) Epigenetics and its role in human cancer. In: Translational bioinformatics and its application. Springer, pp\u00a0249\u2013267","DOI":"10.1007\/978-94-024-1045-7_11"},{"key":"173_CR31","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1080\/07391102.2015.1108870","volume":"34","author":"U Raj","year":"2016","unstructured":"Raj U, Kumar H, Gupta S, Varadwaj PK (2016) Exploring dual inhibitors for STAT1 and STAT5 receptors utilizing virtual screening and dynamics simulation validation. J Biomol Struct Dyn 34:2115\u20132129. https:\/\/doi.org\/10.1080\/07391102.2015.1108870","journal-title":"J Biomol Struct Dyn"},{"key":"173_CR32","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1038\/s41598-017-03534-x","volume":"7","author":"U Raj","year":"2017","unstructured":"Raj U, Aier I, Semwal R, Varadwaj PK (2017) Identification of novel dysregulated key genes in breast cancer through high throughput ChIP-Seq data analysis. Sci Rep 7:3229","journal-title":"Sci Rep"},{"key":"173_CR33","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1093\/bioinformatics\/btp517","volume":"25","author":"G Scardoni","year":"2009","unstructured":"Scardoni G, Petterlini M, Laudanna C (2009) Analyzing biological network parameters with CentiScaPe. Bioinformatics 25:2857\u20132859","journal-title":"Bioinformatics"},{"key":"173_CR34","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.celrep.2016.06.020","volume":"16","author":"EA Semenova","year":"2016","unstructured":"Semenova EA, Kwon M, Monkhorst K et al (2016) Transcription factor NFIB is a driver of small cell lung cancer progression in mice and marks metastatic disease in patients. Cell Rep 16:631\u2013643","journal-title":"Cell Rep"},{"key":"173_CR35","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O et al (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498\u20132504","journal-title":"Genome Res"},{"key":"173_CR36","doi-asserted-by":"publisher","first-page":"6090","DOI":"10.3390\/ijms14036090","volume":"14","author":"H Song","year":"2013","unstructured":"Song H, Kwan S-Y, Izaguirre DI et al (2013) PAX2 expression in ovarian cancer. Int J Mol Sci 14:6090\u20136105","journal-title":"Int J Mol Sci"},{"key":"173_CR37","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ygyno.2011.11.022","volume":"124","author":"C Tian","year":"2012","unstructured":"Tian C, Ambrosone CB, Darcy KM et al (2012) Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study. Gynecol Oncol 124:575\u2013581. https:\/\/doi.org\/10.1016\/j.ygyno.2011.11.022","journal-title":"Gynecol Oncol"},{"key":"173_CR38","doi-asserted-by":"publisher","first-page":"e1138","DOI":"10.1371\/journal.pone.0001138","volume":"2","author":"M Tuefferd","year":"2007","unstructured":"Tuefferd M, Couturier J, Penault-Llorca F et al (2007) HER2 status in ovarian carcinomas: a multicenter GINECO study of 320 patients. Plos One 2:e1138. https:\/\/doi.org\/10.1371\/journal.pone.0001138","journal-title":"Plos One"},{"key":"173_CR39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1349-7006.2009.01434.x","volume":"101","author":"T Ushijima","year":"2010","unstructured":"Ushijima T, Asada K (2010) Aberrant DNA methylation in contrast with mutations. Cancer Sci 101:300\u2013305. https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01434.x","journal-title":"Cancer Sci"},{"key":"173_CR40","doi-asserted-by":"publisher","first-page":"18084","DOI":"10.1074\/jbc.M116.732339","volume":"291","author":"J Wang","year":"2016","unstructured":"Wang J, Galvao J, Beach KM et al (2016) Novel roles and mechanism for kr\u00fcppel-like factor 16 (KLF16) regulation of neurite outgrowth and ephrin receptor A5 (EphA5) expression in retinal ganglion cells. J Biol Chem 291:18084\u201318095","journal-title":"J Biol Chem"},{"key":"173_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ceb.2007.04.011","volume":"19","author":"M Weber","year":"2007","unstructured":"Weber M, Sch\u00fcbeler D (2007) Genomic patterns of DNA methylation: targets and function of an epigenetic mark. Curr Opin Cell Biol 19:273\u2013280. https:\/\/doi.org\/10.1016\/j.ceb.2007.04.011","journal-title":"Curr Opin Cell Biol"},{"key":"173_CR42","doi-asserted-by":"publisher","first-page":"e91770","DOI":"10.1371\/journal.pone.0091770","volume":"9","author":"Y Xia","year":"2014","unstructured":"Xia Y, Chang T, Wang Y et al (2014) YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients. PloS One 9:e91770","journal-title":"PloS One"},{"key":"173_CR43","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1089\/cmb.2012.0023","volume":"19","author":"J Xu","year":"2012","unstructured":"Xu J, Zhang Y (2012) A generalized linear model for peak calling in ChIP-Seq data. J Comput Biol 19:826\u2013838","journal-title":"J Comput Biol"},{"key":"173_CR44","doi-asserted-by":"crossref","first-page":"16951","DOI":"10.18632\/oncotarget.15208","volume":"8","author":"T-L Yeung","year":"2017","unstructured":"Yeung T-L, Leung CS, Wong K-K et al (2017) ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells. Oncotarget 8:16951","journal-title":"Oncotarget"},{"key":"173_CR45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrd1930","volume":"5","author":"CB Yoo","year":"2006","unstructured":"Yoo CB, Jones PA (2006) Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov 5:37\u201350. https:\/\/doi.org\/10.1038\/nrd1930","journal-title":"Nat Rev Drug Discov"},{"key":"173_CR46","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1186\/gb-2008-9-9-r137","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Liu T, Meyer CA et al (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol 9:R137","journal-title":"Genome Biol"}],"container-title":["Network Modeling Analysis in Health Informatics and Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13721-018-0173-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-018-0173-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13721-018-0173-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T18:40:01Z","timestamp":1604774401000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13721-018-0173-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,14]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["173"],"URL":"https:\/\/doi.org\/10.1007\/s13721-018-0173-1","relation":{},"ISSN":["2192-6662","2192-6670"],"issn-type":[{"value":"2192-6662","type":"print"},{"value":"2192-6670","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,14]]},"assertion":[{"value":"22 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"12"}}